Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure

BACKGROUND: Incident heart failure (HF) is increased in persons with human immunodeficiency virus (PHIV). Protease inhibitors (PIs) are associated with adverse cardiac remodeling and vascular events; however, there are no data on the use of PIs in PHIV with HF. OBJECTIVES: This study sought to compa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Am Coll Cardiol
Autores principales: Alvi, Raza M., Neilan, Anne M., Tariq, Noor, Awadalla, Magid, Afshar, Maryam, Banerji, Dahlia, Rokicki, Adam, Mulligan, Connor, Triant, Virginia A., Zanni, Markella V., Neilan, Tomas G.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6202063/
https://ncbi.nlm.nih.gov/pubmed/30049313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2018.04.083
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares